Appili Therapeutics Inc. announced the appointment of Ian C. Mortimer to its Board of Directors. Mr. Mortimer is a seasoned biotechnology executive with proven abilities in leading capital market transactions. He will serve as chair of Appili’s audit committee. Mr. Mortimer has over 20 years of experience in the biotechnology sector. He is currently Chief Financial Officer and Chief Operating Officer of Xenon Pharmaceuticals Inc. Prior to joining Xenon in 2013, Mr. Mortimer spent six years at Tekmira Pharmaceuticals as Executive Vice President and Chief Financial Officer.